A new report questions the efficacy of a drug approved by the FDA to help precent heart attack and stroke in people with a ...

New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...

An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain ...

ICR Healthcare is coordinating meetings on the Company’s behalf. To schedule a meeting with Dr. Phillip Chan, Chief Executive Officer, and Peter J. Mariani, Chief Financial Officer, please send ...

An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the ...

A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ...

Germany: A recent cohort study published in JAMA Network Open has shed light on the comparative outcomes of ticagrelor and ...

PRINCETON, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life ...

A new study supports previous data demonstrating the superiority of prasugrel over ticagrelor in reducing the composite ...

Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...

One of the runways at Vancouver International Airport will be closed for several days after a jet carrying Amazon packages overran it Tuesday morning. The Prime Air Boeing 767-300 operated by ...